EFRANAT
Efranat Ltd. was established in 2009 by, Prof. Nobuto Yamamoto, Boaz Shoam and Avi Levin. The Company was named after Avi and Boaz's wives, Efrat and Anat who died of cancer in 2009. A year before, during their quest to find a cure for their wives’ illness, Avi and Boaz met with Prof. Yamamoto, a world known researcher in the field of Cancer Immunotherapy. Prof. Yamamoto life's work was the discovery of a glycoprotein which he named "GcMAF" (Globulin component Macrophage Activating Factor) a molecule that activates Macrophages,to act against cancer cells.
EFRANAT
Social Links:
Industry:
Health Care Medical
Founded:
2009-01-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.efranat.com
Total Employee:
11+
Status:
Active
Contact:
(972) 897-2497
Email Addresses:
[email protected]
Total Funding:
4.5 M USD
Technology used in webpage:
Content Delivery Network Amazon Google Maps Google Maps API CloudFront OpenResty Google Adsense AWS Global Accelerator AdBlock Acceptable Ads Google Maps For Work
Similar Organizations
Current Employees Featured
Founder
More informations about "Efranat"
Efranat Company Profile 2024: Valuation, Funding & Investors
Efranat General Information Description. Developer of an immunotherapy treatment for cancer based in Rehovot, Israel. The company develops an anticancer immunotherapy treatment …See details»
Efranat Company Profile | Management and Employees List
In healthy human this glycoprotein molecule is activated routinely upon need, in cancer patients its activity is remarkably impair ed. Efranat's drug, EF-022, is manufactured and processed …See details»
Efranat Ltd.: Contact Details and Business Profile
Efranat Ltd. is a clinical stage biotech company focused on immunotherapy for solid tumor cancers and viral diseases (e.g., HPV), starting with an HPV-related orphan indication …See details»
Efranat Ltd. - ContactOut
Efranat Ltd. is a clinical stage biotech company focused on immunotherapy for solid tumor cancers and viral diseases (e.g., HPV), starting with an HPV-related orphan indication …See details»
Efranat Ltd. Overview | SignalHire Company Profile
Efranat Ltd. is a private company that has been in the industry for 14 years. The company currently specializes in the Pharmaceuticals area ... Organization Website: efranat.com : …See details»
Efranat - Overview, News & Similar companies | ZoomInfo.com
View Efranat (www.efranat.com) location in Central District, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Efranat Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Efranat Ltd including stock price, company news, executives, board members, and contact informationSee details»
Efranat Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Last update 01 Nov 2024. Efranat Ltd. Private Company |See details»
Efranat - Company Profile - Tracxn
Sep 27, 2024 Efranat - Cancer immunotherapies based on glycoprotein mimics. Raised a total funding of $4.5M over 2 rounds from 1 investor. Efranat has 2940 competitors.See details»
Efranat - Funding, Financials, Valuation & Investors - Crunchbase
Efranat Ltd. was established in 2009 by, Prof. Nobuto Yamamoto, Boaz Shoam and Avi Levin. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»
Efranat - Products, Competitors, Financials, Employees, …
About Efranat. Efranat specializes in the distribution of CBD gummies within the health and wellness sector. The company offers a range of hemp-derived, non-psychoactive CBD …See details»
Efranat - Contacts, Employees, Board Members, Advisors & Alumni
Efranat Ltd. was established in 2009 by, Prof. Nobuto Yamamoto, Boaz Shoam and Avi Levin.See details»
Efranat - Raised $4.5M Funding from 1 investor - Tracxn
Nov 29, 2024 Efranat has raised a total funding of $4.5M over 2 rounds from 1 investor. Investor includes Battery Ventures. Their latest funding round was of $4.5M on Nov 18, 2014 .See details»
Efranat Pharma - Foreign Startup | Startup Nation Finder
Efranat has succeeded in engineering a natural vitamin D binding protein into a potent immune modulator to fight cancer and chronic viral diseases. The companys primary product, EF-022, …See details»
Efrat
EFRAT provides financial and emotional support to women in crisis who feel they have no alternative but to end their pregnancies due to extreme financial hardship. We give them hope …See details»
Efranat - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Efranat Ltd. was established in 2009 by, Prof. Nobuto Yamamoto, Boaz Shoam and Avi Levin.See details»
Cancer treatment developer Efranat raises $4.5m - Globes
Nov 18, 2014 Efranat, which is developing an innovative treatment for cancer, has raised $4.5 million. The company's treatment is based on the controversial research of a US professor …See details»
Vitamin D binding protein macrophage-activating factor - Efranat
Dec 11, 2017 Efranat is developing EF 022, a modified version of vitamin D binding protein macrophage-activating factor, as an immunotherapy for the treatment of cancer and ... If your …See details»
Honoring EFRAT: An organization that provides support to parents …
Feb 17, 2024 It was posted on the page of EFRAT, an organization that was established by a modern-day hidden tzadik (righteous person), Dr. Eli Schussheim, in 1977, and which …See details»